Trials
(Feb 2022)
Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
- Christopher Kai Shun Leung,
- Seraph Tianmin Ren,
- Poemen Pui Man Chan,
- Kelvin Ho Nam Wan,
- Aziz Ka Wai Kam,
- Gilda Wing Ki Lai,
- Vivian Sheung Man Chiu,
- Match Wai Lun Ko,
- Cedric Ka Fai Yiu,
- Marco Chak Yan Yu
Affiliations
- Christopher Kai Shun Leung
- Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong
- Seraph Tianmin Ren
- Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong
- Poemen Pui Man Chan
- Hong Kong Eye Hospital
- Kelvin Ho Nam Wan
- Hong Kong Eye Hospital
- Aziz Ka Wai Kam
- Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong
- Gilda Wing Ki Lai
- Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong
- Vivian Sheung Man Chiu
- Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong
- Match Wai Lun Ko
- Department of Mechanical Engineering, University of Hong Kong
- Cedric Ka Fai Yiu
- Department of Applied Mathematics, Hong Kong Polytechnic University
- Marco Chak Yan Yu
- Singapore Eye Research Institute
- DOI
-
https://doi.org/10.1186/s13063-022-06079-1
- Journal volume & issue
-
Vol. 23,
no. 1
pp.
1
– 1
WeChat QR code